Position in BMRN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$11,738,395
+$11,365,991 QoQ
Shares Held
207,796
+2922.0% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 99.99085641687039.ToString("F0")%
Shared 0.ToString("F0")%
None 0.009143583129607884.ToString("F0")%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC Bancorp USA Inc. holds $155,785,536 across 65 Biotechnology names. BMRN ranks #4 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
169,031 | $55,927,285 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
63,952 | $28,557,125 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25,263 | $19,519,203 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
207,796 | $11,738,395 | |
| 5 | INCY |
Incyte Corp
|
56,458 | $5,313,826 | |
| 6 | MRNA |
Moderna, Inc.
|
98,515 | $5,004,561 | |
| 7 | TECH |
BIO-TECHNE Corp
|
66,339 | $3,466,875 | |
| 8 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
1,800,000 | $2,808,000 |
All Filings in BMRN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,738,395 | 207,796 | Shares | Defined | 2026-05-12 | |
| 2025-09-30 | $372,404 | 6,876 | Shares | Defined | 2025-11-21 | |
| No filing history on record for this holder in this stock. | ||||||